European drug regulator challenged over revolving door case involving former...
Public health and transparency advocates ask the European Commission if rules regarding conflicts of interest have been sufficiently and duly respected in light of the EMA's decision to allow its...
View ArticleFoundations: Conlicts of interests and Democracy issues
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001020The article ‘Global Health Philanthropy and Institutional Relationships: How Should Conflicts of Interest Be Addressed?‘...
View ArticleEU-Mercosur Trade Negotiations: What Fate for Access to medicines?
Trade negotiators from the EU and Mercosur countries (Argentina, Brazil, Paraguay, Uruguay and Venezuela) will meet next week from 2 to 6 May in Asuncion, Paraguay for the latest round of negotiations...
View ArticleDG Trade public hearing on the “Protection and enforcement of IPR in third...
Today, DG Trade held a public hearingon the “Protection and enforcement of IPR in third countries” from 9.00-13.30, at the Albert Borschette Conference Centre in BrusselsHealth Action International...
View ArticleConflicts of Interest and the Future of Financing for WHO.
Statement on WHO governance and the Management of Conflicts of Interest and the Future of Financing for WHO.We write to express our concerns about governance of the World Health Organization (WHO) and...
View ArticleStatement on Conflicts if Interest delivered at WHA on behalf of HAI, Berne...
Today Health Action International, represented by one of its members, Patrick Durisch, delivered the following statement at the World Health Assembly in Geneva on Agenda Item 13.5 Global Immunization...
View ArticleHAI Europe injects public health perspective into European Research and...
24 May 2011Last Friday, 20 May 2011, Health Action International (HAI) Europe submitted a response to the European Commission consultation on the Common Strategic Framework (CSF) for Research and...
View ArticleSubmission to the Consultative Expert Working Group (CEWG) on alternative...
In June 2011 (HAI) Global, HAI Latin America and the Caribbean (AISLAC) and HAI Europe (HAI-E) made a submission to the Consultative Expert Working Group (CEWG) on alternative financing. For more...
View ArticleArticle 16
20 June 2011 Joint Open Letter to Commissioner Dalli on conflicts of interest at the European Medicines Agency (EMA) and the need for a review of staff regulationsOn 20 June 2011, The Alliance for...
View ArticleArticle 15
HAI Europe's participation at the"Ad hoc meeting - Bilateral trade negotiations: State of Play"HAI Europe will attend the DG Trade Civil Society "Ad hoc meeting - Bilateral trade negotiations: State of...
View ArticleArticle 14
EU Mercosur Trade Negotiations in July All eyes have been on the European Union (EU)-India trade agreement, and the repercussions it will have on access to medicines, not only in India but also in the...
View ArticleArticle 13
TRIPS-Plus IP demands from EU could halt South American trade deal 13 June 2011 Negotiations for a trade agreement between the EU and South American trade bloc Mercosur are approaching yet another...
View ArticleDG Trade State of Play reveals EU's ambitions for IP protection in FTAs
The EU will not be changing its aggressive approach to IP protection in bilateral trade agreements, according to the updates that representatives from the European Commission gave at a State of Play...
View ArticleThe Diagnosis of Childhood Bipolar Disease has led to Catastrophic Consequences
There has been a call for the diagnosis of childhood bipolar disease to be axed from the Diagnostic and Statistical Manual of Mental Disorders (DSM) by one of its early editors. Experts argue that...
View ArticleStudy provides recommendations on European Medicines Agency's communication...
A recently published study produced by an independent expert offers recommendations to assist the European Medicines Agency's communication on the benefits and risks of medicines.The report is a result...
View ArticlePublic Event on EU-MERCOSUR in Buenos Aires
On Friday the 29th of July the first public event on the MERCOSUR-EU negotiations took place in the University of Buenos Aires, Argentina. Organized by the research institute CEIDIE, speakers included...
View ArticleStatement on Medicines Patent Pool
HAI Global and HAI Europe congratulate the Medicines Patent Pool (MPP) on the licensing agreement with generic companies, most notably Aurobindo. The sublicenses are a major step forward in the...
View ArticleEU Policy Opportunities in Biomedical Innovation and the Public Good
Together with the Trans Atlantic Consumer Dialogue (TACD), HAI Europe is currently finalising a policy paper on biomedical innovation for the European level. Sophie Bloemen and David Hammerstein are...
View ArticleStaff Blog has been revived!
The HAI Europe staff blog has been revived! From now on, HAI Europe staff will keep you posted on the most recent political developments and events on access to medicines on this blog.You can also...
View ArticleBracing for another delay - open innovation at the WHO?
Open innovation, open access, crowd-sourcing innovation, innovation prizes.... All buzzwords we often hear in the media, employed by entrepreneurs, government officials or science journalists. The...
View ArticleClik here to view.
Despite concrete steps forward, the ENVI vote on Clinical Trials Regulation...
On 29 May 2013 the European Parliament’s Environment, Public Health and Food Safety (ENVI) Committee voted unanimously in favour of a draft body of rules governing the authorisation and conduct of...
View ArticleGood week for access to affordable medicines
Just days after the United States (US) Supreme Court granted American regulators the legal right to investigate and fine pay-for-delay deals between originator and generics pharmaceutical companies,...
View ArticleClik here to view.
Conference Contemplations: 'Pharmaceuticals and Global Health - Inequalities...
On Friday 19th July, over 150 participants from consumer groups, policy and research bodies, universities, NGOs and industry attended the annual Global Health Conference at the University of Sussex:...
View ArticleClik here to view.
True Clinical Trials Transparency? Not Quite, EFPIA.
Last week, the European Federation of Pharmaceutical Industries and Associations (EFPIA) posted a video on You Tube, called Clinical Trials and Transparency (available here: http://bit.ly/18fYlJp). In...
View ArticleClik here to view.
When Politicians go to the Movies
As part of our co-organised Global Health Summer School in Berlin this September, HAI arranged a preview screening of the documentary film which has been causing a stir across the world since its first...
View Article
